• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建免疫相关和预后 lncRNA 聚类,并鉴定肺腺癌样本中它们的免疫和基因组改变特征。

Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples.

机构信息

Department of Integrated Chinese and Western Medicine, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450008, China.

Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai 200032, China.

出版信息

Aging (Albany NY). 2020 May 23;12(10):9868-9881. doi: 10.18632/aging.103251.

DOI:10.18632/aging.103251
PMID:32445554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7288974/
Abstract

Long non-coding RNAs (lncRNAs) play an important role in various biological processes of lung adenocarcinoma (LUAD), such as immune response regulation, tumor microenvironment remodeling and genomic alteration. Nevertheless, immune-related lncRNAs and their immune and genomic alterations characteristics in LUAD samples still remain unreported. Here, using various public databases, statistic and software tools, we constructed two immune-related lncRNA clusters with different immune and genomic alterations characteristics. Notably, cluster 1 had a stronger immunosuppressive tumor microenvironment (TME) and a higher mutation frequency than cluster 2, especially the mutant genes, such as Kelch-like ECH-associated protein 1 (KEAP1) and toll like receptor 4 (TLR4). In cluster 1, both the amplified and deleted portions of copy number variation (CNV) segments were enriched and cyclin dependent kinase inhibitor 2A (CDKN2A) was significantly deleted. GSVA analysis revealed that these immune-related lncRNAs may be involved in stem cell and EMT functions. Furthermore, cluster 1 was related to worse prognosis of LUAD patients. Therefore, we constructed two immune-related and prognostic lncRNA clusters and identified their immune and genomic alterations characteristics in LUAD samples, which could well divide LUAD patients into different immune phenotypes and help to understand immune molecular mechanisms of LUAD.

摘要

长链非编码 RNA(lncRNAs)在肺腺癌(LUAD)的各种生物学过程中发挥重要作用,例如免疫反应调节、肿瘤微环境重塑和基因组改变。然而,LUAD 样本中的免疫相关 lncRNA 及其免疫和基因组改变特征仍然尚未报道。在这里,我们使用各种公共数据库、统计和软件工具,构建了两个具有不同免疫和基因组改变特征的免疫相关 lncRNA 簇。值得注意的是,簇 1 具有更强的免疫抑制性肿瘤微环境(TME)和比簇 2更高的突变频率,特别是突变基因,如 Kelch-like ECH-associated protein 1(KEAP1)和 toll like receptor 4(TLR4)。在簇 1 中,拷贝数变异(CNV)片段的扩增和缺失部分均被富集,并且 cyclin dependent kinase inhibitor 2A(CDKN2A)显著缺失。GSVA 分析表明,这些免疫相关 lncRNA 可能参与干细胞和 EMT 功能。此外,簇 1 与 LUAD 患者的预后较差相关。因此,我们构建了两个免疫相关且与预后相关的 lncRNA 簇,并鉴定了 LUAD 样本中它们的免疫和基因组改变特征,这可以将 LUAD 患者很好地分为不同的免疫表型,并有助于理解 LUAD 的免疫分子机制。

相似文献

1
Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples.构建免疫相关和预后 lncRNA 聚类,并鉴定肺腺癌样本中它们的免疫和基因组改变特征。
Aging (Albany NY). 2020 May 23;12(10):9868-9881. doi: 10.18632/aging.103251.
2
An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma.一个与外泌体相关的长链非编码 RNA 预后模型与肺腺癌的免疫微环境和治疗反应相关。
Clin Exp Med. 2024 May 18;24(1):104. doi: 10.1007/s10238-024-01319-x.
3
Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.鉴定一个免疫相关的六个长非编码 RNA 特征作为肺腺癌的新型预后生物标志物。
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20202444.
4
Assessment of long non-coding RNA expression reveals novel mediators of the lung tumour immune response.评估长非编码 RNA 表达揭示了肺部肿瘤免疫反应的新介质。
Sci Rep. 2020 Oct 9;10(1):16945. doi: 10.1038/s41598-020-73787-6.
5
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.
6
Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD.构建免疫相关 lncRNA 特征作为 LUAD 的新型预后生物标志物。
Aging (Albany NY). 2021 Aug 26;13(16):20684-20697. doi: 10.18632/aging.203455.
7
Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related IncRNAs in Lung Adenocarcinoma.肺腺癌中 m6A 相关 IncRNAs 的肿瘤免疫微环境综合分析及预后评估
Crit Rev Eukaryot Gene Expr. 2022;32(5):77-91. doi: 10.1615/CritRevEukaryotGeneExpr.2022042417.
8
Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.通过整合基因组规模分析鉴定和验证肺腺癌中的肿瘤微环境表型。
Cancer Immunol Immunother. 2020 Jul;69(7):1293-1305. doi: 10.1007/s00262-020-02546-3. Epub 2020 Mar 18.
9
Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.通过RNA测序对五阴性肺腺癌中与癌症相关的长链非编码RNA和异常可变剪接进行系统鉴定。
Lung Cancer. 2017 Jul;109:21-27. doi: 10.1016/j.lungcan.2017.04.009. Epub 2017 Apr 21.
10
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.泛癌症分析免疫细胞浸润鉴定出肺腺癌预后免疫细胞特征评分(ICCS)。
Front Immunol. 2020 Jun 30;11:1218. doi: 10.3389/fimmu.2020.01218. eCollection 2020.

引用本文的文献

1
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.非小细胞肺癌中长链非编码RNA的综合概况与未来展望:众人拾柴火焰高。
Mol Ther. 2023 Dec 6;31(12):3389-3413. doi: 10.1016/j.ymthe.2023.09.015. Epub 2023 Sep 21.
2
Screening of Immune-related lncRNAs in Lung Adenocarcinoma and Establishing a Survival Prognostic Risk Prediction Model.肺腺癌免疫相关 lncRNAs 的筛选及生存预后风险预测模型的建立。
Comb Chem High Throughput Screen. 2024;27(8):1175-1190. doi: 10.2174/1386207326666230913120523.
3
Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.

本文引用的文献

1
The role of long noncoding RNAs in regulating invasion and metastasis of malignant tumors.长非编码 RNA 在调控恶性肿瘤侵袭转移中的作用。
Anticancer Drugs. 2020 Apr;31(4):319-325. doi: 10.1097/CAD.0000000000000899.
2
The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer.抗 PD-1/PD-L1 免疫疗法治疗晚期非小细胞肺癌患者的进展与困惑。
Int Immunopharmacol. 2020 Mar;80:106247. doi: 10.1016/j.intimp.2020.106247. Epub 2020 Jan 31.
3
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
综合分析表明,m6A 相关长非编码 RNA 与胶质瘤中的各种途径有关。
Cancer Med. 2023 Jan;12(1):760-788. doi: 10.1002/cam4.4913. Epub 2022 Jun 6.
4
Construction of a prognostic immune-related lncRNA model and identification of the immune microenvironment in middle- or advanced-stage lung squamous carcinoma patients.中晚期肺鳞癌患者预后免疫相关lncRNA模型的构建及免疫微环境的鉴定
Heliyon. 2022 May 23;8(5):e09521. doi: 10.1016/j.heliyon.2022.e09521. eCollection 2022 May.
5
Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma.构建免疫相关 lncRNA 特征对预测肺腺癌的肿瘤学结局和免疫抑制剂治疗的敏感性。
Respir Res. 2022 May 13;23(1):123. doi: 10.1186/s12931-022-02043-4.
6
Identification of Atrial Fibrillation-Related lncRNA Based on Bioinformatic Analysis.基于生物信息学分析的房颤相关 lncRNA 的鉴定。
Dis Markers. 2022 Feb 4;2022:8307975. doi: 10.1155/2022/8307975. eCollection 2022.
7
Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma.鉴定免疫相关长链非编码RNA作为肺腺癌的预后标志物
Transl Cancer Res. 2021 Feb;10(2):998-1012. doi: 10.21037/tcr-20-2827.
8
Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer.一种新型免疫相关长链非编码RNA特征及胃癌免疫景观的构建与综合预后分析
Int J Genomics. 2022 Jan 17;2022:4105280. doi: 10.1155/2022/4105280. eCollection 2022.
9
Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients.构建免疫相关 lncRNA 对模型预测肺腺癌患者的预后和免疫图谱。
Bioengineered. 2021 Dec;12(1):4123-4135. doi: 10.1080/21655979.2021.1953215.
10
An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.头颈鳞状细胞癌的免疫相关七长链非编码 RNA 特征。
Cancer Med. 2021 Apr;10(7):2268-2285. doi: 10.1002/cam4.3756. Epub 2021 Mar 3.
基于全基因组拷贝数变异鉴定三个卵巢癌的长链非编码 RNA 预后特征。
Biomed Pharmacother. 2020 Apr;124:109810. doi: 10.1016/j.biopha.2019.109810. Epub 2020 Jan 27.
4
Quantifying the benefit of non-small-cell lung cancer immunotherapy.量化非小细胞肺癌免疫疗法的益处。
Lancet. 2019 Nov 23;394(10212):1904. doi: 10.1016/S0140-6736(19)32503-6.
5
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection.TLRs 在抗肿瘤免疫和肿瘤排斥中的作用。
Front Immunol. 2019 Oct 22;10:2388. doi: 10.3389/fimmu.2019.02388. eCollection 2019.
6
Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.基于突变子衍生的长链非编码 RNA 基因组不稳定性特征的计算鉴定,以改善癌症的临床预后:以乳腺癌为例的研究。
Brief Bioinform. 2020 Sep 25;21(5):1742-1755. doi: 10.1093/bib/bbz118.
7
Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer.泛癌中影响长链非编码RNA表达的体细胞突变的综合特征分析
Mol Ther Nucleic Acids. 2019 Dec 6;18:66-79. doi: 10.1016/j.omtn.2019.08.004. Epub 2019 Aug 14.
8
Emerging roles of lncRNA in cancer and therapeutic opportunities.长链非编码RNA在癌症中的新作用及治疗机会
Am J Cancer Res. 2019 Jul 1;9(7):1354-1366. eCollection 2019.
9
LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.长链非编码 RNA TTN-AS1 通过海绵吸附 miR-142-5p 调控 CDK5 促进肺腺癌迁移、侵袭和上皮间质转化。
Cell Death Dis. 2019 Jul 30;10(8):573. doi: 10.1038/s41419-019-1811-y.
10
Cellular functions of long noncoding RNAs.长非编码 RNA 的细胞功能。
Nat Cell Biol. 2019 May;21(5):542-551. doi: 10.1038/s41556-019-0311-8. Epub 2019 May 2.